Openwater CEO Aaron Timm Delivers Keynote at Hamlyn Symposium Workshop on Open-Source Medical Robotics

Timm presented "An Open-Source Platform to Fight Disease" at the Royal Geographical Society, London, spotlighting Openwater's open-source approach to medical device innovation.

SAN FRANCISCO, CA, UNITED STATES, June 26, 2026 — Openwater, an open-source medical technology company delivering portable, hospital-grade diagnostic and therapeutic research devices, today announced that CEO Aaron Timm delivered a keynote address at the Hamlyn Symposium on Medical Robotics workshop, "From Code to Care: Challenges, Success Stories, and the Future Directions of Open-Source Development in Medical Robotics," held at the Royal Geographical Society in London, UK.

Timm's keynote, titled "An Open-Source Platform to Fight Disease," was presented to an international audience of researchers, engineers, clinicians, and industry leaders from institutions including Johns Hopkins University, Harvard Medical School, ETH Zürich, Georgia Institute of Technology, and NVIDIA. The workshop brought together professionals from academia, industry, and regulatory communities to exchange real-world experiences and explore the future of open-source development in medical technology.

The workshop convened experts to address some of the most pressing questions in medical robotics: how open-source platforms can be responsibly commercialized, how regulatory compliance can be integrated into open development models, and how globally accessible technologies can improve patient outcomes, including in low- and middle-income countries. The event was organized by leading researchers from University College London, Brigham and Women's Hospital, Harvard Medical School, and Johns Hopkins University, and was accredited for 6 Continuing Professional Development (CPD) points.

"Open-source development is not a compromise. It is a competitive advantage when it comes to speed, transparency, and trust," said Aaron Timm, CEO of Openwater. "Our platform is designed from the ground up to be shared, validated, and built upon by the global research community, and that is how we drive real clinical impact."

Openwater's presence at the Hamlyn Symposium underscores the company's commitment to open-source innovation as a core strategy for medical device development and commercialization.

Openwater's open-source research platform encompasses two flagship devices: Open-LIFU, a portable low-intensity focused ultrasound (LIFU) system that delivers noninvasive neuromodulation and therapeutic capabilities to precise regions of the brain and body; and Open-Motion, a wearable near-infrared diagnostic platform designed for real-time blood flow and blood volume monitoring. Together, these systems reflect Openwater's vision of a modular, multi-purpose medical technology ecosystem. Shared open-source hardware and software frameworks allow academic institutions, clinical researchers, and commercial partners.